This issue of the Biomedical Journal tells us about the risks of electronic cigarette smoking, variations of SARS-CoV-2 and ACE2, and how COVID-19 affects the gastrointestinal system. Moreover, we learn that cancer immunotherapy seems to work well in elderly patients, how thyroid hormones regulate noncoding RNAs in a liver tumour context, and that G6PD is a double-edged sword of redox signalling. We also discover that Perilla leaf extract could inhibit SARS-CoV-2, that artificial neural networks can diagnose COVID-19 patients and predict vaccine epitopes on the Epstein–Barr Virus, and that men and women have differential inflammatory responses to physical effort. Finally, the surgical strategies for drug-resistant epilepsy, computer-supervised double-jaw surgery, dental pulp stem cell motility, and the restitution of the brain blood supply after atherosclerotic stroke are discussed.
【저자키워드】 Cancer immunotherapy, G6PD, SARS-CoV-2 mutations, Electronic cigarettes, Epstein–Barr virus vaccine, 【초록키워드】 COVID-19, SARS-CoV-2, ACE2, Vaccine, stroke, Variation, risk, surgical, smoking, epilepsy, elderly patients, Brain, hormone, noncoding RNA, Thyroid, epitope, liver, predict, Blood, diagnose, Inflammatory response, regulate, COVID-19 patient, atherosclerotic, effort, journal, gastrointestinal system, Affect, physical, Cell, men and women, drug-resistant, inhibit SARS-CoV-2, Perilla,